Welcome to our dedicated page for Axt SEC filings (Ticker: AXTI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AXT, Inc. filings document the regulatory disclosures of a Nasdaq-listed manufacturer of compound semiconductor substrate wafers. Recent Form 8-K reports cover results of operations and financial condition, Regulation FD information, exhibit filings for earnings releases, and capital-structure disclosures involving its common stock.
The filing record also includes material definitive agreement disclosure for an underwriting agreement, exchange-registration information for AXTI common stock, and definitive proxy materials addressing shareholder voting matters, board and committee governance, director independence, and executive compensation.
AXT, Inc., through its subsidiary Beijing Tongmei Xtal Technology Co., Ltd., entered into a long‑term supply agreement with Nanjing Casela Technologies Corporation, Ltd. for indium phosphide wafer substrates for the 2027 calendar year.
Casela has a binding commitment to purchase a fixed aggregate quantity of InP wafers for a total price of RMB 173,000,000 (approximately US $25.4 million), with deliveries scheduled monthly. Casela must prepay 50% of the total price within 15 business days after signing, with the remaining 50% due on or before December 31, 2026.
Casela is required to purchase at least 80% of the committed quantity or pay a cancellation fee on the shortfall. If Casela’s demand exceeds the committed quantity, Tongmei will, subject to available capacity and on terms no less favorable than those for similarly situated customers, prioritize the additional demand under supplemental terms. Fundamental breaches such as order cancellation, failure to take delivery, extended payment delinquency, or missing the 80% threshold allow Tongmei to terminate the agreement and retain amounts already paid.
AXT Inc. director Jesse Chen sold shares of the company in the open market. On June 15, 2026, Chen sold 6,172 shares of AXT common stock at a weighted average price of $115.2437 per share, in multiple trades between $113.38 and $116.69. After these sales, Chen directly owned 50,275 shares of AXT common stock.
AXT Inc. director David C. Chang reported an open-market sale of 8,333 shares of Common Stock on June 15, 2026 at an average price of $111.1715 per share. After this transaction, he directly holds 65,165 shares, indicating he retains a substantial equity position in the company.
AXT Inc director and CEO Morris S. Young reported a bona fide gift of 1,200 shares of common stock held indirectly through the Young Family Trust. The transaction carried no sale price and is classified as a gift disposition, not an open-market trade.
Following the transfer, indirect holdings reported for the trust total 2,148,333 shares of AXT common stock. The footnotes state that Young is subject to a lock-up agreement related to an underwritten public offering, expiring on June 20, 2026, and that this gift is expressly permitted under that agreement.
AXT Inc director Jesse Chen reported two open-market sales of Common Stock. On June 11, 2026, he sold 9,000 shares at a weighted average price of $88.5481 per share. On June 12, 2026, he sold 13,000 shares at a weighted average price of $95.7738 per share.
After these transactions, Chen directly held 56,447 shares of AXT Inc Common Stock. Footnotes note that the reported prices are weighted averages for multiple trades on each day, with individual sale prices ranging within specified intraday price bands.
AXT Inc. director Jesse Chen reported open-market sales of AXT common stock over three days in June 2026. He sold a total of 16,500 shares on June 8–10, 2026 at weighted average prices, with individual trades executed in ranges from $83.00 to $95.88. After these transactions, Chen directly owns 78,447 shares of AXT common stock.
AXT, Inc. reported results of its 2026 Annual Meeting and a change to its charter. Stockholders approved an amendment to the Restated Certificate of Incorporation to increase authorized common shares from 70,000,000 to 120,000,000, effective upon filing on June 4, 2026.
As of the March 20, 2026 record date, 56,944,925 common shares were outstanding, with 28,907,223 shares (about 52%) represented, establishing a quorum. Stockholders elected Dr. Morris Young and Dr. David Chang as Class I directors, approved an advisory vote on executive compensation, ratified BPM as independent auditor for 2026, and approved both the share-authorization amendment and a related adjournment proposal.
AXTI filed a Rule 144 notice reporting an affiliate sale notice for Common Stock. The filing shows a sale of 20,000 shares on 03/10/2026 with a reported value of $919,918.00. The record lists Nasdaq as the market and includes prior equity compensation items such as RSA and an Open Market Purchase entry dated 09/08/2004.
AXT Inc. director Jesse Chen reported both an equity grant and share sales. On June 4, 2026, Chen received a grant of 754 shares of common stock as an annual equity award, valued using the $105.99 closing price on the grant date and scheduled to vest on May 14, 2027.
Chen also sold 4,000 shares of common stock on June 3, 2026 at a weighted average price of $111.3600, and 6,133 shares on June 4, 2026 at a weighted average price of $108.2788. The filing notes that each sale consisted of multiple trades within price ranges of $106.68 to $114.36 and $105.32 to $112.26, respectively. After these transactions, Chen directly held 94,193 shares of AXT common stock.
LEBLANC LEONARD J reported acquisition or exercise transactions in this Form 4 filing.
AXT Inc. director Leonard J. LeBlanc received an equity grant of 754 shares of Common Stock. The shares were granted at no cash cost to him as a compensation award and are based on a reference price of $105.99 per share, the closing price on the June 4, 2026 grant date.
Following this grant, LeBlanc directly holds 119,629 shares of AXT common stock. The award is structured to vest on May 14, 2027, meaning the director earns full rights to the shares on that future date if vesting conditions are met.